Stefan John

Summary

Affiliation: University of Erlangen-Nuremberg
Country: Germany

Publications

  1. ncbi Renal replacement strategies in the ICU
    Stefan John
    Department of Nephrology and Hypertension, University of Erlangen Nuremberg, Krankenhausstrasse 12, 91054 Erlangen, Germany
    Chest 132:1379-88. 2007
  2. ncbi Renal replacement therapy in the treatment of acute renal failure-intermittent and continuous
    Stefan John
    Department of Nephrology and Hypertension, University of Erlangen Nuremberg, Erlangen, Germany
    Semin Dial 19:455-64. 2006
  3. ncbi Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension
    Markus P Schneider
    Department of Medicine IV/Nephrology, , Erlangen, Germany
    Am J Hypertens 18:1111-7. 2005
  4. ncbi Nitric oxide and reactive hyperemia: role of location and duration of ischemia
    Ulrike Raff
    Department of Nephrology and Hypertension, University of Erlangen Nuremberg, Germany
    Am J Hypertens 23:865-9. 2010
  5. ncbi Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients
    Stefan John
    Department of Medicine IV, University of Erlangen Nurnberg, Erlangen, Germany
    Am Heart J 149:473. 2005
  6. ncbi Life-threatening thrombotic thrombocytopenic purpura associated with dental foci. Report of two cases
    Matthias Fenner
    Department of Oral and Maxillofacial Surgery, University of Erlangen Nuremberg, Germany
    J Clin Periodontol 31:1019-23. 2004
  7. ncbi Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension
    Christian Stumpf
    Medical Clinic II, University of Erlangen Nuremberg, Erlangen, Germany
    J Hypertens 23:995-1000. 2005
  8. ncbi Effect of elevated triglyceride levels on endothelium-dependent vasodilation in patients with hypercholesterolemia
    Markus P Schneider
    Department of Medicine/Nephrology, , , Germany
    Am J Cardiol 91:482-4. 2003
  9. ncbi Practice and perception--a nationwide survey of therapy habits in sepsis
    Frank M Brunkhorst
    Anesthesiology and Intensive Care Medicine, Friedrich Schiller University Jena, Germany
    Crit Care Med 36:2719-25. 2008
  10. ncbi Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension
    Christian Delles
    Department of Medicine IV/Nephrology, , , Germany
    Kidney Int 61:1462-8. 2002

Collaborators

Detail Information

Publications21

  1. ncbi Renal replacement strategies in the ICU
    Stefan John
    Department of Nephrology and Hypertension, University of Erlangen Nuremberg, Krankenhausstrasse 12, 91054 Erlangen, Germany
    Chest 132:1379-88. 2007
    ....
  2. ncbi Renal replacement therapy in the treatment of acute renal failure-intermittent and continuous
    Stefan John
    Department of Nephrology and Hypertension, University of Erlangen Nuremberg, Erlangen, Germany
    Semin Dial 19:455-64. 2006
    ..Moreover, it will be discussed whether patients with sepsis and septic shock benefit from early RRT initiation, the use of increased RRT doses, and increased removal of inflammatory mediators by RRT...
  3. ncbi Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension
    Markus P Schneider
    Department of Medicine IV/Nephrology, , Erlangen, Germany
    Am J Hypertens 18:1111-7. 2005
    ..We conclude that NAC is therefore not an effective superoxide scavenger in vivo. Other, nonimmediate effects such as the generation of glutathione may explain the beneficial effects of NAC in conditions associated with oxidative stress...
  4. ncbi Nitric oxide and reactive hyperemia: role of location and duration of ischemia
    Ulrike Raff
    Department of Nephrology and Hypertension, University of Erlangen Nuremberg, Germany
    Am J Hypertens 23:865-9. 2010
    ....
  5. ncbi Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients
    Stefan John
    Department of Medicine IV, University of Erlangen Nurnberg, Erlangen, Germany
    Am Heart J 149:473. 2005
    ..We investigated whether improvement in NO availability in hypercholesterolemia can be achieved rapidly with statins before lipid-lowering therapy is complete...
  6. ncbi Life-threatening thrombotic thrombocytopenic purpura associated with dental foci. Report of two cases
    Matthias Fenner
    Department of Oral and Maxillofacial Surgery, University of Erlangen Nuremberg, Germany
    J Clin Periodontol 31:1019-23. 2004
    ..The therapy requires a multi-disciplinary team approach involving dentistry. Even if TTP is immediately treated in an adequate manner, it still shows a mortality of up to 20%...
  7. ncbi Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension
    Christian Stumpf
    Medical Clinic II, University of Erlangen Nuremberg, Erlangen, Germany
    J Hypertens 23:995-1000. 2005
    ..Therefore, the present pilot study was designed to examine the role of platelet P-selectin and various inflammatory mediators in young patients with moderate AH without signs of target organ damage...
  8. ncbi Effect of elevated triglyceride levels on endothelium-dependent vasodilation in patients with hypercholesterolemia
    Markus P Schneider
    Department of Medicine/Nephrology, , , Germany
    Am J Cardiol 91:482-4. 2003
  9. ncbi Practice and perception--a nationwide survey of therapy habits in sepsis
    Frank M Brunkhorst
    Anesthesiology and Intensive Care Medicine, Friedrich Schiller University Jena, Germany
    Crit Care Med 36:2719-25. 2008
    ..To simultaneously determine perceived vs. practiced adherence to recommended interventions for the treatment of severe sepsis or septic shock...
  10. ncbi Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension
    Christian Delles
    Department of Medicine IV/Nephrology, , , Germany
    Kidney Int 61:1462-8. 2002
    ..The effects of eprosartan on RPF are mediated, at least in part, by an increased bioavailability of nitric oxide in the renal vasculature...
  11. ncbi Assessment of endothelial function of the renal vasculature in human subjects
    Christian Delles
    Department of Medicine/Nephrology, , Germany
    Am J Hypertens 15:3-9. 2002
    ..The prolonged effect of L-NMMA and L-arginine must be taken into account in study protocols using both substances. Thus, stimulation and blockade of NO synthase cannot be examined in the same protocol...
  12. ncbi Effect of AT1 receptor blockade on endothelial function in essential hypertension
    Arnfried U Klingbeil
    Department of Medicine IV, , , Germany
    Am J Hypertens 16:123-8. 2003
    ..CONCLUSIONS: The AT(1) receptor blockade with valsartan improved basal NO production and release. The effect seems to be BP independent, as BP reduction with HCTZ failed to increase NO availability...
  13. ncbi The C242T p22phox polymorphism and endothelium-dependent vasodilation in subjects with hypercholesterolaemia
    Markus P Schneider
    Universitat Erlangen Nurnberg, Medizinische Klinik IV 4, Klinikum Nürnberg Süd, Breslauer Strasse 201, D 90471 Nuremberg, Germany
    Clin Sci (Lond) 105:97-103. 2003
    ....
  14. ncbi Vitamin C augments the renal response to L-arginine in smokers
    Markus P Schneider
    Department of Medicine/Nephrology, , Germany
    Nephrol Dial Transplant 18:1512-7. 2003
    ..arginine alone induced a similar increase of RPF. The co-infusion of vitamin C and -arginine led to a greater increase of RPF and GFR in smokers. This might suggest that oxidative stress is increased in the renal vasculature of smokers...
  15. ncbi Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia
    Stefan John
    Department of Medicine IV, , , Breslauerstr 201, , Germany
    Curr Hypertens Rep 5:199-207. 2003
    ..Statins and blockers of the renin-angiotensin system seem to have such antioxidative effects independent from their effects on lipid profiles or blood pressure control...
  16. ncbi Intensive insulin therapy and pentastarch resuscitation in severe sepsis
    Frank M Brunkhorst
    Department of Anesthesiology and Intensive Care Medicine, Friedrich Schiller University, Jena, Germany
    N Engl J Med 358:125-39. 2008
    ..The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids...
  17. ncbi Acute renal failure in patients with severe sepsis and septic shock--a significant independent risk factor for mortality: results from the German Prevalence Study
    Michael Oppert
    Department of Nephrology and Medical Intensive Care, Charite Universitatsmedizin Berlin, Humboldt University, 13353 Berlin, Germany
    Nephrol Dial Transplant 23:904-9. 2008
    ..Further, it is not known whether ARF is an independent risk factor for mortality in septic patients or merely an indicator of disease severity...
  18. ncbi Impact of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects
    Johannes Jacobi
    Department of Medicine/Nephrology, , Germany
    J Hypertens 20:525-30. 2002
    ..8 +/- 3.9 versus -4.1 +/- 3.8 beats/min, P = NS) to a similar extent in both groups. CONCLUSION : Basal NO synthesis of the renal vasculature is not impaired in patients with established essential hypertension...
  19. ncbi Epidemiology of sepsis in Germany: results from a national prospective multicenter study
    Christoph Engel
    Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Haertelstrasse 16 18, 04107, Leipzig, Germany
    Intensive Care Med 33:606-18. 2007
    ..To determine the prevalence and mortality of ICU patients with severe sepsis in Germany, with consideration of hospital size...
  20. ncbi AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study
    Arnfried U Klingbeil
    Department of Medicine IV, , Germany
    J Hypertens 20:2423-8. 2002
    ..01). CONCLUSIONS: Blood pressure reduction with the AT receptor antagonist valsartan but not with hydrochlorothiazide reduced the augmentation index in essential hypertension...
  21. ncbi Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension
    Christian Delles
    Department of Medicine/Nephrology, , , Germany
    Am J Hypertens 15:590-3. 2002
    ..CONCLUSIONS: Levels of ADMA were reduced with enalapril and eprosartan therapy. Our results suggest a specific action of these drugs on ADMA levels that is independent of BP...